Quality of Life Index

Abstract

The Quality of Life Index (QL-Index), often referred to as the Spitzer QL-Index, is a concise, multidimensional Psychological Scale developed for the rapid assessment of a patient’s overall well-being, particularly in clinical settings involving chronic or terminal illnesses. Originally designed for use with cancer patients, this instrument provides both a clinician-rated version and a self-assessment version. The scale is structured around five key domains: Activity, Daily living, Health, Support, and Outlook. Each dimension is scored on a simple ordinal scale (0, 1, or 2 for the clinician version), yielding a total score that reflects the patient’s functional status and subjective quality of life. Its brevity and ease of administration make it a valuable tool for tracking changes in a patient’s condition over time and aiding in prognostic uncertainty, especially in Palliative Care.

Keywords

Quality of Life Index, Spitzer QL-Index, QoL, functional status, clinician rating, self-assessment, oncology, chronic disease, palliative care, psycho-social support.

Authors

Walter O. Spitzer, A.J. Dobson, J. Hall, S. Suissa, S.C. Shenker, S. Wood-Dauphinee, J.I. Williams.

[quads id=5]

Purpose

The primary purpose of the Quality of Life Index is to provide a quick, reliable, and clinically useful measure of the comprehensive well-being of patients suffering from serious or chronic conditions, such as Oncology and Chronic Diseases. It was specifically developed to be concise enough for routine use by physicians and clinicians, allowing for efficient monitoring of patient decline or improvement in response to treatment or disease progression.

The index serves two critical functions: first, as a tool for clinical research to measure outcomes beyond survival rates; and second, as a practical measure to help clinicians quantify prognostic uncertainty, particularly in terminal care. By evaluating specific functional and psychosocial domains, the scale offers a structured way to gauge the patient’s capacity for daily activities, their perceived health status, and their psychological outlook, providing a holistic perspective often missed by purely physiological measures.

Construct

The Quality of Life Index is designed to measure the multidimensional construct of health-related quality of life (HRQoL) by assessing five distinct, yet interrelated, domains of functioning and well-being. These domains capture physical, functional, and psychological aspects of the patient’s life over the preceding week, allowing for high sensitivity to recent changes in condition.

The five domains include Activity (work, study, or household management capacity), Daily living (self-care and mobility), Health (subjective physical well-being and energy levels), Support (quality of relationships and availability of social support), and Outlook (emotional state, anxiety, depression, and sense of control). In the Clinician Rating Version, each domain is scored from 0 (poor) to 2 (excellent), resulting in a potential total score ranging from 0 to 10. Higher scores indicate better quality of life. The Self-assessment version uses a 3-point rating for each item, typically scored 1, 2, or 3, providing comparable qualitative assessment.

Validity

Studies supporting the Spitzer QL-Index have demonstrated strong evidence of its validity, particularly in the context of oncology and chronic illness populations. The scale exhibits strong face validity and content validity, as the five dimensions cover areas commonly recognized by clinicians and patients as central to quality of life.

Furthermore, the QL-Index has shown robust concurrent validity, correlating significantly with other established measures of functional status, such as the Karnofsky Performance Status (KPS). Research has also highlighted its predictive validity, demonstrating its ability to accurately predict survival time in patients with advanced cancer, often providing prognostic information superior to physician judgment alone. Cross-validation studies, such as those conducted by Suissa, Shenker, and Spitzer (1984), confirm its applicability and stability across different chronically ill patient groups.

Reliability

The reliability of the Quality of Life Index is generally considered acceptable for a brief clinical instrument, though reliability metrics can vary based on the version used (clinician vs. self-report) and the patient population heterogeneity. A key strength of the Clinician Rating Version is its high inter-rater reliability, meaning different health professionals tend to assign similar scores to the same patient, indicating clear, objective scoring criteria.

Measures of internal consistency (e.g., Cronbach’s alpha) typically fall in the acceptable range, suggesting that the five items cohere to measure a single underlying construct of overall quality of life. Studies, including those reviewed by Wood-Dauphinee and Williams (1991), confirm its consistency and dependability in monitoring patient status over short intervals, making it suitable for longitudinal tracking during clinical trials or treatment regimens.

Factor Analysis

While the Quality of Life Index is fundamentally a multi-item, single-score index, factor analyses have generally supported the concept of a single dominant factor representing overall quality of life, which accounts for a substantial portion of the variance. Although the scale is conceptually divided into five domains, the high inter-correlation among these items often leads researchers to treat the total score as the primary outcome measure.

The original design emphasized clinical relevance and ease of scoring over strict psychometric factor separation, leading to a highly practical instrument. Subsequent analyses confirm that while the five subscales contribute uniquely to the patient profile, summing them provides a meaningful and sensitive index of global well-being, especially useful for quick prognostic classification.

Instrument

Test Type: Multidimensional Health-Related Quality of Life Index (Clinician Rating and Self-Assessment versions).

Format: Five-item index with ordinal response options (3 levels per item).

Language Available: Primarily English, but widely translated and used globally in clinical settings.

Population Group: Patients suffering from chronic, serious, or life-limiting illnesses.

Age Group: Adults (primarily), though applicable to adolescents with suitable contextual adaptation.

Population Details: Originally validated on patients with cancer, subsequently applied to various chronically ill populations (e.g., renal failure, AIDS). It is especially valued in palliative and supportive care.

Test Methodology: Brief assessment, typically taking less than five minutes to complete or administer. The clinician version relies on observable behavior and reported status over the previous week. The self-assessment relies on the patient’s subjective report over the same time frame.

Keywords

QL-Index scoring, prognostic tool, functional status measures, psychological assessment, health outcome measurement, Spitzer, terminal illness, patient reported outcomes (PROs), clinician reported outcomes (CROs).

[quads id=5]

Authors

Author ORCID Identifier: Not uniformly available across all original authors; typically referenced via institutional affiliation.

Affiliation Email addresses: Unavailable.

Correspondence Address: Original correspondence was often directed to the Department of Clinical Epidemiology, McGill University, Montréal, Québec (W.O. Spitzer).

Permissions & Fee and Test Year

The Spitzer QL-Index is generally considered to be in the public domain for non-commercial research and clinical use due to its widespread adoption and publication in core academic journals. No specific fee is typically required for clinical use. The original scale was published in 1981.

The original PDF of the instrument, as referenced in the source content, can be downloaded here: www.a4ebm.org/sites/default/files/Measuring%20Health.pdf

Reference’s

• Spitzer‚ W.O.‚ Dobson‚ A.J.‚ Hall. J.‚ et al. (1981). Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians. Journal of Chronic Diseases‚ 34(12): 585–597.

• Suissa‚ S.‚ Shenker‚ S.C.‚ Spitzer‚ W.O. (1984). Measuring the quality of life of cancer and chronically ill patients: cross-validation studies of the Quality of Life Index. [Manuscript] Montréal‚ Québec: Department of Clinical Epidemiology‚McGill University.

• Wood-Dauphinee‚ S.‚ Williams‚ J.I. (1991). The Spitzer Quality-of-Life Index: its performance as a measure. In: Osoba D‚ ed. Effect of cancer on quality of life. Boca Raton‚ Florida: CRC Press‚ 1991:169–184.

• Spitzer‚ W.O. (1988). Quality of life. In: Burley D‚ Inman WHW‚ eds. Therapeutic risk: perception‚ measurement‚ management. New York: John Wiley & Sons‚ 35–46.

• Addington-Hall‚J.M.‚ MacDonald‚ L.D. & Anderson‚ H.R. (1990). Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br. J. Cancer‚ 62‚ 695-699.

• McDowell‚ Ian. (2006). Measuring Health: A Guide to Rating Scales and Questionnaires‚ Third Edition. OXFORD UNIVERSITY PRESS.

[quads id=5]

Items of the Quality of Life Index

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.